Breaking News: LLY – Market Insights, Analysis & Latest Updates

LLY
NOVOb

Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints

Novo Nordisk's obesity drug CagriSema showed a 22.7% weight loss in trials, disappointing investors and causing a significant drop in market value amid fierce competition.

investing.com • 20/12/2024 - 11:21 AM

In weight loss battle, Novo and Lilly face growing offensive from licensed copies

Novo Nordisk and Eli Lilly face competition from cheaper drug copies abroad, threatening their market share and prompting potential price declines amid rising global obesity rates.

investing.com • 20/12/2024 - 01:04 AM

LLY

Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over

Eli Lilly's stock dropped slightly despite the FDA declaring the tirzepatide shortage resolved, although a trade group claims ongoing supply issues persist for compounded versions.

investing.com • 19/12/2024 - 19:25 PM

BIIB
LLY

Eli Lilly's Alzheimer's treatment approved in China

Eli Lilly’s Kisunla is approved in China for early Alzheimer's, marking a new treatment option alongside Leqembi, with specific dosing and safety profiles.

investing.com • 18/12/2024 - 01:50 AM

Eli Lilly Alzheimer’s drug donanemab approved in China

Eli Lilly's Kisunla treatment for Alzheimer's has been approved in China, following its approval in the U.S., Japan, and the UK, marking an important milestone in Alzheimer’s therapies.

investing.com • 18/12/2024 - 01:15 AM

LLY
NVO

US FDA warns online vendors selling unapproved weight-loss drugs

The FDA issued warning letters to four companies for selling unapproved GLP-1 drugs, indicating misuse of labeling that misled consumers about FDA approval and intended use.

investing.com • 17/12/2024 - 22:30 PM

Insurer stocks fall after Trump says 'we're going to knock out the middleman'

Trump's criticism of pharmacy benefit managers caused shares of major health insurers to drop, igniting debate about drug pricing and proposals to eliminate middlemen in the industry.

investing.com • 16/12/2024 - 20:44 PM

LLY
NVO

Weight-loss drugs draw Americans back to the doctor

Powerful weight-loss drugs are increasing diagnoses of obesity-related conditions and fueling patient engagement, while also impacting eligibility for various medical services and surgeries.

investing.com • 16/12/2024 - 11:05 AM

LLY
NOVOb

Eli Lilly's Manjaro gains on Novo Nordisk's Wegovy in UK

Eli Lilly's Manjaro is surpassing Novo Nordisk's Wegovy in the UK weight loss market, attributed to its higher efficacy, but is not yet available through the NHS.

investing.com • 13/12/2024 - 14:21 PM

LLY
NVO

How we got to a global obesity epidemic and how GLP-1 is a game-changer

The article discusses the global obesity epidemic, its causes, and the potential of GLP-1 medications as effective treatments, while noting challenges in access and adherence.

investing.com • 13/12/2024 - 14:09 PM

Currency